Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
Data(s) |
02/04/2009
|
---|---|
Resumo |
Statins reduce the incidence of cardiovascular events in patients at high cardiovascular risk. However, a benefit of statins in such patients who are undergoing hemodialysis has not been proved. |
Identificador | |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Fellström , B C , Jardine , A G , Schmieder , R E , Holdaas , H , Bannister , K , Beutler , J , Chae , D-W , Chevaile , A , Cobbe , S M , Grönhagen-Riska , C , De Lima , J J , Lins , R , Mayer , G , McMahon , A W , Parving , H-H , Remuzzi , G , Samuelsson , O , Sonkodi , S , Sci , D , Süleymanlar , G , Tsakiris , D , Tesar , V , Todorov , V , Wiecek , A , Wüthrich , R P , Gottlow , M , Johnsson , E , Zannad , F , AURORA Study Group & Maxwell , A 2009 , ' Rosuvastatin and cardiovascular events in patients undergoing hemodialysis ' New England Journal of Medicine , vol 360 , no. 14 , pp. 1395-407 . DOI: 10.1056/NEJMoa0810177 |
Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700 #Medicine(all) |
Tipo |
article |